Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Other Non-Current Assets (2016 - 2026)

Perspective Therapeutics' Other Non-Current Assets history spans 16 years, with the latest figure at $490000.0 for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets rose 33.88% to $490000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $490000.0, a 33.88% increase, with the full-year FY2025 number at $486000.0, up 20.0% from a year prior.
  • Other Non-Current Assets hit $490000.0 in Q1 2026 for Perspective Therapeutics, up from $486000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for CATX hit a ceiling of $490000.0 in Q1 2026 and a floor of $182000.0 in Q1 2022.
  • Historically, Other Non-Current Assets has averaged $267000.0 across 5 years, with a median of $182000.0 in 2022.
  • Biggest five-year swings in Other Non-Current Assets: changed 0.0% in 2022 and later soared 122.53% in 2024.
  • Tracing CATX's Other Non-Current Assets over 5 years: stood at $182000.0 in 2022, then changed by 0.0% to $182000.0 in 2023, then soared by 122.53% to $405000.0 in 2024, then increased by 20.0% to $486000.0 in 2025, then grew by 0.82% to $490000.0 in 2026.
  • Business Quant data shows Other Non-Current Assets for CATX at $490000.0 in Q1 2026, $486000.0 in Q4 2025, and $438000.0 in Q3 2025.